deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT01807611

Haploidentical Donor Hematopoietic Progenitor Cell and NK Cell Transplantation for Hematologic Malignancy

Haploidentical Donor Hematopoietic Progenitor Cell and Natural Killer Cell Transplantation With a TLI Based Conditioning Regimen in Patients With Hematologic Malignancies

Sponsor: Assisi Foundation

Updated 21 times since 2017 Last updated: Oct 28, 2022 Started: May 16, 2013 Primary completion: Aug 27, 2021 Completion: Sep 27, 2021
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Leukemia and Lymphoma and is currently completed. Assisi Foundation leads this study, which shows 21 recorded versions since 2013 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Apr 2017 · 59 days · monthly snapshot~Apr 2017 – ~Jun 2018 · 14 months · monthly snapshot~Jun 2018 – ~Nov 2018 · 5 months · monthly snapshot~Nov 2018 – ~Sep 2019 · 10 months · monthly snapshot~Sep 2019 – ~Feb 2020 · 5 months · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jul 2020 · 3 months · monthly snapshot~Jul 2020 – ~Sep 2020 · 2 months · monthly snapshot~Sep 2020 – ~Oct 2020 · 30 days · monthly snapshot~Oct 2020 – ~Jan 2021 · 3 months · monthly snapshot~Jan 2021 – ~Apr 2021 · 3 months · monthly snapshot~Apr 2021 – ~Sep 2021 · 5 months · monthly snapshot~Sep 2021 – ~Oct 2021 · 30 days · monthly snapshot~Oct 2021 – ~Nov 2021 · 31 days · monthly snapshot~Nov 2021 – ~Nov 2022 · 12 months · monthly snapshot~Nov 2022 – ~Dec 2022 · 30 days · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

21 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE2

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE2

  5. Nov 2022 — Dec 2022 [monthly]

    Completed PHASE2

Show 16 earlier versions
  1. Nov 2021 — Nov 2022 [monthly]

    Completed PHASE2

    Status: Active Not RecruitingCompleted

  2. Oct 2021 — Nov 2021 [monthly]

    Active Not Recruiting PHASE2

  3. Sep 2021 — Oct 2021 [monthly]

    Active Not Recruiting PHASE2

  4. Apr 2021 — Sep 2021 [monthly]

    Active Not Recruiting PHASE2

  5. Jan 2021 — Apr 2021 [monthly]

    Active Not Recruiting PHASE2

  6. Oct 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE2

  7. Sep 2020 — Oct 2020 [monthly]

    Active Not Recruiting PHASE2

  8. Jul 2020 — Sep 2020 [monthly]

    Active Not Recruiting PHASE2

  9. Apr 2020 — Jul 2020 [monthly]

    Active Not Recruiting PHASE2

  10. Feb 2020 — Apr 2020 [monthly]

    Active Not Recruiting PHASE2

    Status: RecruitingActive Not Recruiting

  11. Sep 2019 — Feb 2020 [monthly]

    Recruiting PHASE2

  12. Nov 2018 — Sep 2019 [monthly]

    Recruiting PHASE2

  13. Jun 2018 — Nov 2018 [monthly]

    Recruiting PHASE2

  14. Apr 2017 — Jun 2018 [monthly]

    Recruiting PHASE2

  15. Feb 2017 — Apr 2017 [monthly]

    Recruiting PHASE2

  16. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE2

    First recorded

May 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Assisi Foundation
  • St. Jude Children's Research Hospital
Data source: St. Jude Children's Research Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations